UnknownPhase 4ketamine

Adductor Canal Block in Total Knee Arthroplasty

Sponsored by Assiut University

NCT ID
NCT05715437
Target Enrollment
60 participants
Start Date
2023-03
Est. Completion
2024-12

About This Study

The purpose of this study is to evaluate whether adding ketamine to bupivacaine is superior to bupivacaine alone in terms of providing better pain control for 48 hours postoperatively after TKA.

Conditions Studied

Analgesia

Interventions

  • •Bupivacaine plus Normal Saline
  • •Bupivacain and ketamine

Eligibility

Age:18 Years - 80 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

1. The subject is scheduled for elective primary unilateral TKA.
2. The subject is ≥ 18 years and ≤ 80 years.
3. Both sexes.
4. The subject's primary anesthesia care team has planned for a spinal anesthesia.
5. The patient agrees to receive an adductor canal block.
6. ASA class 1-3.

Exclusion Criteria:

1. Subject is \< 18 years of age or \>80 years of age.
2. Subject is known or believed to be pregnant.
3. Significant pre-existing neuropathy on the operative limb.
4. Significant renal, cardiac or hepatic disease.
5. ASA class 4-5.

This trial is not recruiting

This study is currently not accepting new participants.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Adductor Canal Block in Total Knee Arthroplasty | Huxley